Opioid Agonist Treatment Linked to Lower Mortality in French Primary Care
Personalized briefing
Discovery of the day · Public Health
[Articles] Opioid agonist treatment and risk of mortality in French primary care: a nationwide, retrospective cohort study
Dear jacqueline dunbar-jacob, this is your personalized scientific intelligence briefing — curated for your work in Public Health.
Key finding
Medicine · Public Health
Discovery of the day
A large nationwide cohort study of French primary care patients initiating opioid agonist treatment (OAT) demonstrated a substantial reduction in all-cause mortality risk associated with treatment exposure. The protective effect was particularly pronounced for buprenorphine, though the authors caution that indication bias — whereby healthier patients may be preferentially prescribed buprenorphine — could partly explain the finding. For a nurse and psychologist focused on chronic disease and health behavior, this evidence reinforces the critical role of medication-assisted treatment in reducing mortality among individuals with opioid use disorder, a high-risk chronic condition, and underscores the need for continued advocacy and patient engagement in treatment retention.
Novelty
82%
Rigor
91%
Significance
90%
Validity
85%
Clarity
93%
Advertisement
ScientificChina — verified Chinese lab & medical equipment suppliers, direct. Browse suppliers →
Your briefing is personalized based on your selected fields, keywords, and research interests.
